▪ RP2D is the dose that does not exceed the DLT limit established by the. dose escalation plan. ▪ Often it is exceeded during the course of a phase 1 study. ▪ The dose escalation scheme is guided by the DLTs that occur during. the observation period, but the safety and tolerability determinations.
Hope this helps…
▪ RP2D is the dose that does not exceed the DLT limit...
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.82 |
Change
0.170(4.66%) |
Mkt cap ! $1.187B | |||
| Open | High | Low | Value | Volume |
| $3.80 | $3.88 | $3.55 | $10.15M | 2.701M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1301 | $3.82 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.85 | 1690 | 1 |
View Market Depth
| Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$3.80 |
Change
0.170 ( 3.91 %) |
||||
| Open | High | Low | Volume | ||
| $3.78 | $3.87 | $3.55 | 179402 | ||
| Last updated 15.59pm 06/05/2024 ? | |||||
| CU6 (ASX) Chart |